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Key points summary 
• Hypoglycaemia is counteracted by release of hormones and an increase in 
ventilation and CO2 sensitivity to restore blood glucose levels and prevent a fall 
in blood pH. 
• The full counter-regulatory response and an appropriate increase in ventilation is 
dependent on carotid body stimulation. 
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• We show that the hypoglycaemia-induced increase in ventilation and CO2 
sensitivity is abolished by preventing adrenaline release or blocking its 
receptors. 
• Physiological levels of adrenaline mimicked the effect of hypoglycaemia on 
ventilation and CO2 sensitivity. 
• These results suggest that adrenaline, rather than low glucose, is an adequate 
stimulus for the carotid body mediated changes in ventilation and CO2 
sensitivity during hypoglycaemia to prevent a serious acidosis in poorly 
controlled diabetes. 
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Abstract 
 
Hypoglycaemia in vivo induces a counter-regulatory response that involves the release 
of hormones to restore blood glucose levels. Concomitantly, hypoglycaemia evokes a 
carotid body mediated hyperpnoea that maintains arterial CO2 levels and prevents 
respiratory acidosis in the face of increased metabolism. It is unclear whether the carotid 
body is directly stimulated by low glucose or by a counter-regulatory hormone such as 
adrenaline. Minute ventilation was recorded during infusion of insulin-induced 
hypoglycaemia (8-17 mIU kg-1min-1) in Alfaxan-anaesthetized male Wistar rats. 
Hypoglycaemia significantly augmented minute ventilation (123±4 to 143±7 ml min-1) 
and CO2 sensitivity (3.3±0.3 to 4.4±0.4 ml min-1 mmHg-1). These effects were abolished 
by either β-adrenoreceptor blockade with propranolol or adrenalectomy. In this 
hypermetabolic, hypoglycaemic state, propranolol stimulated a rise in PaCO2, 
suggestive of a ventilation-metabolism mismatch. Infusion of adrenaline (1µg kg-1 min-
1) increased minute ventilation (136±4 to 161±5 ml min-1) without altering PaCO2 or pH 
and enhanced ventilatory CO2 sensitivity (3.4±0.4 to 5.1±0.8 ml min-1 mmHg-1). These 
effects were attenuated by either resection of the carotid sinus nerve or propranolol. 
Physiological concentrations of adrenaline increased the CO2 sensitivity of freshly 
dissociated carotid body type I cells in vitro.  These findings suggest that adrenaline 
release can account for the ventilatory hyperpnoea observed during hypoglycaemia by 
an augmented carotid body and whole body ventilatory CO2 sensitivity. 
 
 
Abbreviations: ABP, arterial blood pressure; Adr, adrenaline; AdrX, adrenalectomy; 
CB, carotid body; CSNX, carotid sinus nerve section; HC, hypercapnia; HG, 
hypoglycaemia; Prop, propranolol; fR, respiratory frequency; ሶܸ E, minute ventilation; VT, 
tidal volume   
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Introduction 
 
In mammals, regulation of arterial blood glucose is an essential process that allows for 
maintenance of glycolysis and ATP production. The counter-regulatory response to 
hypoglycaemia (HG) is highly integrated and involves a number of neuro-endocrine 
responses arising from stimulation of multiple peripheral and central glucose sensors 
including the gastrointestinal tract, portal mesenteric vein, hypothalamus and hindbrain 
(Bohland et al., 2014).  More recently it has been suggested that, in addition to their 
more recognised role as hypoxia sensors (Kumar & Prabhakar, 2012) the carotid body 
(CB) chemoreceptors may also play a key role in mediating the counter-regulatory 
response to HG in both animals and humans (Alvarez-Buylla & de Alvarez-Buylla, 
1988; Koyama et al., 2000; Wehrwein et al., 2010; Limberg et al., 2015; Wehrwein et 
al., 2015) with corrective reflexes being attenuated by carotid body ablation either 
surgically or chemically. Although an assumption has been made that the reduction in 
plasma glucose concentration is directly sensed by the carotid body, this remains 
controversial and the exact stimulus that excites the CB during HG in vivo remains 
undetermined. 
Thus, the evidence that long-term, reduced in vitro CB preparations are acutely 
stimulated by low glucose (Pardal & Lopez-Barneo, 2002; Garcia-Fernandez et al., 
2007; Zhang et al., 2007) has been countered by findings that freshly isolated intact 
CBs and dissociated type I cells lack any inherent low glucose sensitivity (Bin-Jaliah et 
al., 2004; Conde et al., 2007; Kim et al., 2011; Gallego-Martin et al., 2012; Holmes et 
al., 2014). In view of this, it has been suggested that the CB-mediated reflex changes 
observed in HG may be an indirect action in response to a systemically released 
hormone(s) rather than low glucose per se (Kumar, 2007; Ribeiro et al., 2013; Holmes 
et al., 2014). HG is known to promote the release of glucagon, cortisol, noradrenaline 
(NA) and adrenaline (Adr) (Ward et al., 2007; Wehrwein et al., 2010). Of these, NA 
and Adr are recognised respiratory stimulants; exogenous infusion of NA, Adr or 
adrenergic agonists increase minute ventilation in humans (Heistad et al., 1972; Butland 
et al., 1982) and similar findings have been reported in animals (Joels & White, 1968; 
Folgering et al., 1982; Hauton et al., 2013). This ventilatory response can be attenuated 
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by Propranolol (Prop), carotid sinus nerve section (CSNX) and hyperoxia, consistent 
with a role for both β-adrenoreceptors and CB chemoreceptors (Joels & White, 1968; 
Folgering et al., 1982). Subcutaneous injection of Adr also increases CB cAMP content, 
an effect attributed to β-adrenoreceptor stimulation (Mir et al., 1983). Additionally, Adr 
augments CO2 production as evidenced by increases in the respiratory exchange ratio 
(RER), the rate of glycogen breakdown and metabolism in skeletal muscle (Watt et al., 
2001). These actions of Adr may account for the reflex hyperpnoea previously observed 
in HG and which has been shown to be critically dependent on an increase in CB 
chemoafferent activity mediated by an increase in CB CO2 sensitivity (Bin-Jaliah et al., 
2004, 2005). As yet, however, a potential role for Adr in evoking the hyperpnoea and 
enhanced CB CO2 sensitivity during HG has not been investigated.  
Using whole animal in vivo experimentation we show here that, during HG, Adr 
released from the adrenal medulla is sufficient to evoke hyperpnoea by increasing 
ventilatory CO2 sensitivity. Adr infusion mimics the effect of HG and enhances the CB 
type I cell response to CO2. Thus, the importance of CB activation by Adr during HG 
appears not only to help restore arterial blood glucose levels but also to control PaCO2 
and pH, thereby preventing respiratory acidosis. 
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Methods 
Ethical approval 
The following procedures on animals were carried out in line with the current Home 
Office (UK) and University of Birmingham guidelines on ethical use of animals. Food 
and water was available ad libitum, until food was withdrawn from 8 hours before 
experimentation to ensure stable basal blood glucose levels. 
 
Anaesthesia and surgery 
Adult male Wistar rats (Charles River Laboratories) were initially anaesthetised with 3-
4% isoflurane in O2 at 3-4 L min-1 (Merial Animal Health Ltd). Following cannulation 
of the right jugular vein, isoflurane was removed and anaesthesia was maintained with 
i.v. Alfaxan® (Vétoquinol UK Ltd), at 17-20 mg kg-1 h-1 with 0.1 ml boluses as 
necessary. Core body temperature was maintained at 37°C with a homeothermic heat 
pad system. 
 
The trachea was cannulated and a spirometer was attached to measure airflux; 
respiratory frequency (fR), tidal volume (Vt) and minute ventilation ( ሶܸ E = fR  x Vt) were 
derived from this. Animals breathed room air throughout, except when inspiratory gases 
were changed to induce hypercapnia (HC; 8% CO2 for 5 min). The tracheal cannula was 
connected to a system of rotameters in a gas proportioner frame (CP Instruments Co. 
Ltd) allowing variation of inspiratory gases. The response to HC was calculated as the 
mean of the last 2 min of the exposure to HC after ventilation had stabilised. 
 
Arterial Blood Pressure (ABP) was measured from the right brachial artery and heart 
rate (HR) was derived. Femoral blood flow (FBF; Transonic Systems Inc) was 
measured from the left femoral artery. Arterial blood samples were taken from the right 
femoral artery, utilising a looped cannula technique to reduce blood loss when sampling 
pure mixed arterial blood. Arterial blood was used to monitor blood glucose (0.6 µl; 
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Accu-Chek®, Aviva) and blood gases (150 µl; Gem® 4000 premier analyser, 
Instrumentation Laboratory Ltd). Arterial blood gases were measured prior to, and in 
the final 2 min of, the exposure to HC. Drug infusions were given via the right femoral 
vein. 
 
For adrenalectomy (AdrX) experiments, a midline incision was made and the kidneys 
located. The adrenal glands were located bilaterally, vascularly isolated and removed. 
For CSNX experiments, the carotid artery bifurcations were isolated, the carotid sinus 
nerves identified and sectioned bilaterally at the junction with the glossopharyngeal 
nerve. Denervation was confirmed by the absence of a response to hypoxia (as 
described previously by Bin Jaliah et al 2004, 2005). Following surgery, a 40 min 
stabilisation period was allowed before commencing the experimental protocols. 
 
Data were recorded using PowerLab and Labchart software (ADInstruments Ltd). At 
the end of the experiment, animals were killed by overdose of Euthatal® (pentobarbital 
sodium, 200 mg ml-1, Merial Animal Health Ltd) and cervical dislocation. 
 
In vivo experimental protocols 
A diagrammatic representation of the protocols used in the in vivo experiments below 
can be seen in Figure 1. 
 
Group 1: Hyperinsulinaemic hypoglycaemia 
ሶܸ E was recorded before and during insulin infusion (n=12; 304±7g). Insulin (Hypurin® 
Bovine Neutral, CP Pharmaceuticals Ltd) was diluted in Gelofusine® (4% w/v, Dechra 
Veterinary Products) and infused at 8-17 mIU kg-1 min-1 to induce HG (blood glucose = 
3.1±0.1 mmol L-1). Once blood glucose reached the target level, the insulin infusion rate 
was titrated to keep it at a stable level. The response to HC (to determine CO2 
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sensitivity; Δ ሶܸ E / mmHg PaCO2) was recorded before and approximately 30 min after 
the insulin infusion was started. Blood glucose and gas samples were taken periodically 
throughout each experiment as described above. After recovery from HG, animals were 
assigned to one of two subgroups; one animal did not fully recover and so was not 
assigned to a subgroup, whilst an additional two animals were used in the development 
of the AdrX protocol. 
Group 1A: Hyperinsulinaemic hypoglycaemia with propranolol 
Prop was infused (0.3 mg kg-1 min-1; P0884 - Sigma®, n=6; 308±8g) for 10 min until 
HR stabilised. This dose was shown to significantly antagonise the effects of Adr 
infusion (see Figure 5C). The response to HC was repeated before and during a further 
insulin infusion. 
Group 1B: Hyperinsulinaemic hypoglycaemia with adrenalectomy 
Following AdrX, the response to HC was repeated before and during HG (n=7; 
284±8g). 
 
Group 2: Adrenaline infusion 
Adr (E4250, Sigma®) was infused at 3 different concentrations (0.1, 1 & 10 µg kg-1 
min-1) to determine a dose that increased ሶܸ E whilst minimising effects on ABP (see 
Figure 4). This dose (1 µg kg-1 min-1) was subsequently used for all other experiments: 
ሶܸ E (n=30; 321±7g) and the effect of HC (n=14) were recorded before and during Adr 
infusion. After recovery from Adr, animals were assigned to one of two subgroups; 8/30 
animals were used only for the Adr dose-response experiments to develop the protocol. 
Group 2A: Adrenaline infusion with propranolol 
Prop was infused and basal ሶܸ E and the response to HC assessed as in Group 1A. These 
responses were repeated during combined Prop and Adr infusion (n=14; 333±12g). 
Group 2B: Adrenaline infusion with carotid sinus nerve section 
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Following CSNX, basal ሶܸ E was recorded and the response to HC was repeated before 
and during Adr infusion (n=8; 312±7g). 
 
Carotid body type I cell isolation and Ca2+ imaging 
The following procedures comply with the National Institute of Health guide for the 
care and use of laboratory animals (NIH publications No. 80-23, revised 1996) and were 
approved by the Wright State University Institutional Laboratory Animal Care and Use 
Committee. 
 
CBs were isolated from Sprague-Dawley rats (12-19 days old) anaesthetised with 
isoflurane (4.5% in O2) and digested in an enzyme solution containing 0.4 mg mL-1 
collagenase type I (Worthington Biochemical Corporation) and 0.2 mg mL-1 trypsin 
type I (Sigma) in DPBS with low CaCl2 (86 µM) and MgCl2 (350 µM), for 20 min at 
37°C. CBs were mechanically dissociated with forceps and incubated for an additional 7 
min. The tissue was centrifuged (115g) for 3 min, supernatant removed and the pellet 
re-suspended in tissue culture medium (Ham’s F12 (Sigma) supplemented with 10% 
heat inactivated fetal bovine serum (Biowest). Cells were released by trituration with 
fire polished silanized Pasteur pipettes (Sigmacote, Sigma). Type I cells were plated on 
15 mm round poly-d-lysine coated (0.1 mg mL-1) glass coverslips (Warner Instruments) 
and incubated at 37°C in 5% CO2, 10% O2, for at least two hours before being used. All 
experiments were performed within 8 hours of isolation. 
 
Type I cells were loaded with 5 μM FURA-2AM (Invitrogen) in serum free F-12 Ham’s 
nutrient media for 30 min at room temperature in a humidified chamber at 5% CO2, 
10% O2, before being transferred to FURA-2AM free media in the same conditions for 
at least 20 min before imaging. Coverslips were placed in an RC-25F (Warner 
Instruments) recording chamber (approximate bath volume 500 µL), with gravity fed 
pre-heated solution being maintained at 34-36°C with an in-line heater (SH-27F, 
Warner Instruments) with thermistor controlled feedback (TC-344B, Warner 
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Instruments), and solution removed with a Rainin-Dynamax RP-1 peristaltic pump at 
maximum flow rate (8 mL min-1). Although the chamber is open to ambient air, the 
gravity-fed, pump-emptied chamber is less than 500µL in volume and perfusate is 
flowing at ~8mL.min-1 allowing for less mixing with ambient air than might occur at 
slower flow rates. The PO2 in the superfusate in the chamber during gassing with 10% 
O2 (76 Torr) equilibrated Tyrodes was around 11% O2 (~85 Torr).  Image acquisition 
was controlled by Metafluor software (Molecular Devices) and cells were visualized 
using a Nikon TE2000-U inverted microscope with a CFI super fluor x40 oil immersion 
objective. The FURA-2 loaded cells were excited by 50 ms exposures to 340/380 nm 
light using a Lambda 10-3 filter wheel (Sutter) and emitted light was recorded at 510 
nm using a Coolsnap HQ2 CCD camera (Photometrics) - images were recorded every 5 
s.  
 
Cells were continuously perfused with a standard bicarbonate buffered Tyrode solution 
containing in mM: 117 NaCl, 4.5 KCl, 11 Glucose, 23 NaHCO3, 2.5 CaCl2, 1 MgCl2, 
equilibrated with 10% O2, 5% CO2, pH 7.4 at 37°C. By gassing solutions with 10% O2 
we maintained a more physiological environment for the isolated type I cells. Previous 
work from multiple groups on isolated type I cells has gassed solutions with 21% O2, 
which is extreme hyperoxia. HC was induced by equilibrating extracellular solutions 
with 15% CO2, 10% O2, balance N2. Type I Cells were exposed to two successive 30 
second episodes of HC, with the second being performed in the presence or absence of 
10 nM Adr. The change in fluorescence ratio (F340/F380) from baseline to peak (delta 
ratio F340/F380) was measured for each challenge and the percentage change between the 
first and second exposure calculated. To minimise Adr oxidation to adrenochrome, Adr 
was prepared in solutions containing 1 mM ascorbic acid– final experimental 
concentration 125 nM. 
 
Data analysis 
All data is presented as the mean ± SEM. Statistics were carried out using GraphPad 
Prism 5 (GraphPad) and graphs were plotted using Deltagraph (Red Rock Software). 
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Significance (p<0.05) was tested using repeated measures or one-way ANOVA with 
post-hoc Bonferroni tests, and paired or unpaired t-tests as appropriate. 
  
12 
 
Results 
 
Ventilatory and cardiovascular responses to hypoglycaemia  
An example trace illustrating the effect of inducing HG on cardiovascular and 
respiratory variables is shown in Figure 2A. Reducing blood glucose levels from 
6.1±0.3 mM to 3.1±0.1 mM induced an approximately 20% increase in minute 
ventilation (ΔVE +20±4ml.min-1, n=12, p<0.05) with no concomitant increase in PaCO2, 
demonstrating a hyperpnoea (Figure 2B). The HG-induced increase in ሶܸ E was blocked 
by Prop infusion (ΔVE -12±3ml.min-1, n=6, p>0.05) and PaCO2 increased in 5 out of 6 
rats, although this was not statistically significant (Prop 37±2mmHg vs Prop + HG 
41±2mmHg, p=0.06). AdrX blocked the increase in ሶܸ E initiated by HG (ΔVE -
1±2ml.min-1, n=7, p>0.05), but PaCO2 was unaffected (see Figure 2C).  
 
Hypoglycaemia-induced changes in CO2 sensitivity  
To examine the impact of HG on respiratory CO2 sensitivity, the ventilatory response to 
HC was recorded under normoglycaemic and hypoglycaemic conditions. As expected, 
HC increased ሶܸ E in both glycaemic states, but importantly this was exaggerated in HG 
(Normoglycaemia Δ ሶܸ E +66±6 vs HG +82±7ml min-1, n=11, p<0.05, Figure 3A). The 
ventilatory CO2 sensitivity (defined as the increase in ሶܸ E per mmHg increase in PaCO2), 
was significantly increased by HG (Control 3.3±0.3 vs HG 4.4±0.4ml.min-1mmHg-1, 
n=11, p<0.05, Figure 3A). The ventilatory response to HC during Prop infusion was not 
different to control, however, Prop reduced the CO2 sensitivity during HG (Prop 3.1±0.2 
vs Prop+HG 1.4±0.2ml.min-1mmHg-1, n=6, p<0.05, Figure 3B). Following AdrX, the 
response to HC and calculated CO2 sensitivity was not different to control, however the 
HG-mediated augmentation in CO2 sensitivity was abolished (AdrX 4.5±0.9 vs AdrX + 
HG 3.2±0.9ml.min-1mmHg-1, n=7, p>0.05, Figure 3C). 
 
Responses to adrenaline infusion  
To further explore the acute effect of Adr on respiratory control, we measured ሶܸ E during 
exogenous Adr infusion. Adr stimulated a dose-dependent increase in ሶܸ E (Baseline = 
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136±4, Adr at 0.1 µg kg min-1 = 146±4, 1 µg kg min-1 = 161±5 and 10 µg kg min-1 = 
189±9ml min-1, p<0.05) without altering ABP, except at the highest dose (ABP at 1 µg 
kg min-1 = 129±2 and 10 µg kg min-1 = 146±3mmHg, n=30, p<0.05, Figure 4). Thus, in 
further experiments Adr was infused at 1 µg kg min-1, to rule out the possibility that any 
modifications in ሶܸ E caused by Adr were an indirect consequence of a change in ABP.       
 
Carotid body dependent responses evoked by adrenaline infusion  
Figure 5A is an example trace showing the responses evoked by an Adr infusion (1 µg 
kg min-1). Adr stimulated a hyperpnoea: no change in PaCO2 despite an approximately 
20% increase in ሶܸ E (Δ ሶܸ E +25±3ml min-1, n=30, p<0.05, Figure 5B). However, in the 
presence of Prop, the ሶܸ E response to Adr was diminished (ΔVE +9±4ml min-1, n=14, 
p>0.05) and PaCO2 increased significantly (Prop 41±1 vs Prop + Adr 48±4mmHg, 
p<0.05, Figure 5C), consistent with a ሶܸ E -metabolism mismatch. Following CSNX, 
PaCO2 was significantly elevated compared to control (39±1 vs 47±2mmHg, p<0.05). 
The increase in ሶܸ E stimulated by Adr was significantly attenuated by CSNX (ΔVE 
+6±2ml min-1, n=8, p<0.05), but PaCO2 did not increase further (Figure 5C). 
 
Adrenaline-induced changes in CO2 chemosensitivity  
To investigate a potential role for Adr in modifying ventilatory CO2 sensitivity, 
responses to HC were measured under control conditions and during Adr infusion. Adr 
increased the ሶܸ E response to HC (Control ΔVE +59±5 vs Adr +75±11 ml min-1, p<0.05, 
Figure 6A) and the calculated CO2 sensitivity (Control 3.4±0.4 vs Adr 5.1±0.8 ml min-1 
mmHg-1, n=14, p<0.05, Figure 6A). The Adr-induced increase in CO2 sensitivity was 
completely blocked by Prop administration (Prop 3.0±0.4 vs Prop + Adr 2.6±0.5 ml 
min-1 mmHg-1, n=6, p>0.05, Figure 6B) and by CSNX (CSNX 4.0±0.9 vs CSNX + Adr 
3.6±0.6 ml min-1 mmHg-1, n=5, p>0.05, Figure 6C).  
 
Hypercapnia-induced increases in Type I cell Ca2+ levels  
Isolated type I cells were loaded with Fura-2 and their responses to hypercapnic stimuli 
recorded. Figure 7A is a typical trace showing the control responses to HC. Baseline 
fluorescence was usually noisy when gassing with 10% rather than 21% O2 (see (Burlon 
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et al., 2009) for examples of quiet baselines at 21%) but 100% of cells recorded from 
responded rapidly with a rise in the fluorescence ratio when exposed to HC. The second 
exposure to HC was smaller than the first (see Figure 7A and C). By contrast, Figure 7B 
shows the effect of Adr (10nM) on the responses to HC. Adr had no effect on baseline 
activity but potentiated the second response to HC. Figure 7C shows the percentage 
difference between the second peak response to HC and the first under control 
conditions (-11±5.8%, n=10) and in the presence of 10nM Adr (+9±8.1%, n=9). The 
potentiating effect of Adr on HC responses was statistically significant (p<0.05, 
unpaired t-test). 
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Discussion 
 
HG has been associated with a CB-mediated increase in ventilation and CO2 sensitivity 
(Bin-Jaliah et al., 2004, 2005). We show here for the first time that the in vivo 
augmentation of minute ventilation during HG is prevented by either β-adrenoreceptor 
blockade or AdrX. This supports the idea that glucose sensing in vivo is not a direct 
effect of low glucose on the CB but rather a consequence of Adr release. These same 
two interventions also counteracted the HG-induced increase in ventilatory CO2 
sensitivity. Adr infusion mimicked the action of HG by evoking hyperpnoea and by 
increasing ventilatory CO2 sensitivity in vivo. These responses are dependent on the 
intact sensory neuronal input from the CB chemoreceptors, as demonstrated by the 
effect of CSNX. We have also shown that physiological concentrations of Adr increase 
the CO2 sensitivity of freshly dissociated CB type I cells. These findings therefore 
suggest that Adr release during HG is necessary to evoke hyperpnoea and causes an 
increase in CB and whole body ventilatory CO2 sensitivity and is consistent with Adr 
having a major role in the counter-regulatory response to HG.   
 
A role for adrenaline in mediating hyperpnoea in hypoglycaemia 
The emerging consensus is that the CB is stimulated during HG and contributes to the 
counter-regulation required to restore a normal plasma glucose concentration (Koyama 
et al., 2000; Wehrwein et al., 2010; Limberg et al., 2015; Wehrwein et al., 2015). This 
function is reliant on a heightened chemoafferent input into the NTS that in turn leads to 
the augmentation of Adr secretion from the adrenal medulla and an increase in hepatic 
glucose release into the systemic circulation (Alvarez-Buylla & de Alvarez-Buylla, 
1988; Alvarez-Buylla et al., 1997).  Perhaps as importantly, activation of the CB 
chemoreceptors during HG is also essential to increase ventilation in a way that 
precisely matches the concurrent rise in metabolic rate, thereby preventing a rise in 
PaCO2 which if uncorrected could result in a serious systemic acidosis (Bin-Jaliah et al., 
2004).  
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Despite these key homeostatic functions, there remains a debate as to whether the CB 
responds either directly and rapidly to low glucose, or indirectly to some other blood-
borne stimulus released as a consequence of systemic HG. The global counter-
regulatory response to HG is multi-faceted and highly integrated and includes 
sympathetic activation (Fagius et al., 1986), systemic hypokalaemia (Petersen et al., 
1982), and an increase in whole body metabolism (Bin-Jaliah et al., 2004). In addition, 
a number of counter-regulatory endocrine or neuroendocrine factors are released into 
the systemic circulation including Adr, NA, cortisol and glucagon (Cryer, 1993; Ward 
et al., 2007).  
 
We have shown that Prop administration and AdrX are both effective in abolishing the 
HG-induced increase in ventilation. Prop administration during HG caused a rise in 
PaCO2, suggestive of a failure to match ventilation to an increased metabolism. Since 
AdrX also blocked the increase in ventilation during insulin-induced HG, it suggests 
that the hyperpnoea is not driven by insulin per se. This is in agreement with an earlier 
study where a euglycaemic-hyperinsulinaemic clamp did not augment ventilation (Bin-
Jaliah et al., 2004) however, differs from the paper by (Ribeiro et al., 2013) who 
concluded the CB response was insulin-triggered. Additionally, there is evidence that 
insulin can act centrally in the arcuate nucleus of the hypothalamus to stimulate 
sympathetic nerve activity (Cassaglia et al., 2011). We have no explanation for this 
difference in results, however, HG may not be the only stimulus for Adr release. 
Furthermore, exogenous infusion of Adr at levels insufficient to cause ABP changes 
increased ሶܸ E without altering PaCO2 or pH, indicative of hyperpnoea. Since this latter 
effect was markedly attenuated by CSNX, the action of Adr appears to be targeted to the 
CB chemoreceptors. That said, the presence of a small but significant increase in 
ventilation caused by Adr infusion after CSNX suggests that a small component of this 
response is CB-independent. Prop administration during Adr infusion abolished the 
increase in ሶܸ E and caused a significant increase in PaCO2, indicative of ventilation-
metabolism mismatch. We have also previously shown that the ventilatory response to 
HG is absent following CSNX (Bin-Jaliah et al., 2004). Collectively, the data presented 
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here suggest that Adr released from the adrenal medulla during HG is necessary to 
stimulate hyperpnoea, via the activation of β-adrenoreceptors and stimulation of the CB.  
 
Abolishing the HG-mediated increase in ventilation with either AdrX or Prop also 
provides new evidence that the CB is not stimulated directly by low glucose in vivo. 
This supports previous work where the freshly isolated intact in vitro CB or dissociated 
type I cells were found to lack any inherent low glucose sensitivity (Bin-Jaliah et al., 
2004; Conde et al., 2007; Kim et al., 2011; Gallego-Martin et al., 2012; Holmes et al., 
2014). Since our HG is of rapid onset, our data supports the sensing of low glucose 
centrally (Ibrahim et al., 2003; Burdakov et al., 2005; Fioramonti et al., 2007) to drive 
sympathetic activation and Adr release from the adrenal medulla into the blood (Levin 
et al., 2008). The downstream effect of this is CB activation. 
 
Adrenaline release in hypoglycaemia augments carotid body and ventilatory CO2 
sensitivity  
Enhanced CB activity in HG is coupled with an elevation in ventilatory CO2 sensitivity 
(Bin-Jaliah et al., 2005). After birth, CB chemosensitivity matures rapidly in the first 
week (Kholwadwala & Donnelly, 1992) and plateaus in the second week (Bamford et 
al., 1999). Thus, a robust mature response to CO2 would be expected in our isolated 
type I cells. Our data shows that Adr increases CB type I cell Ca2+ responses to HC in 
vitro and also augments the ventilatory response to HC in vivo. In both instances, dual 
application of Adr and HC produced multiplicative responses, signifying stimulus 
interaction. Thus, exogenous Adr increases the CB and ventilatory sensitivity to CO2. 
Additionally, it is unlikely that Adr alters central CO2 chemoreceptor function directly 
since peripheral Adr does not cross the blood brain barrier (Axelrod & Tomchick, 
1958). However, since the excitability of medullary CO2 sensitive neurones can be 
regulated by the input from the peripheral chemoreceptors (Blain et al., 2010; Smith et 
al., 2015), it is conceivable that Adr indirectly enhances central respiratory CO2 
sensitivity via its action on the CB. Importantly, we also demonstrate that the normal 
increase in ventilatory CO2 sensitivity in HG is inhibited by AdrX and Prop. This 
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therefore indicates that endogenous Adr release in HG enhances the CB and ventilatory 
CO2 sensitivity of the whole animal. The possibility that the in vivo CB and ventilatory 
CO2 sensitivity is further augmented by a substance released as a consequence of Adr 
release and β-adrenoreceptor stimulation is also plausible. The mechanism driving Adr 
release from the adrenal medulla in HG is expected to be an increase in sympathetic 
nerve activity. Interestingly the ventilatory CO2 sensitivity was actually reduced in HG 
during Prop infusion. Whilst the main catecholamine released during HG is Adr, there is 
also release of NA (Jokiaho et al., 2014). It is possible that, during β-adrenoreceptor 
blockade with Prop infusion, NA released by HG is acting on inhibitory α2-
adrenoceptors in the CB to reduce CO2 sensitivity (Kou et al., 1991; Prabhakar & Kou, 
1994; Almaraz et al., 1997).  
 
Effects of different glucose sensors during hypoglycaemia 
Multiple central and peripheral glucose sensors have been identified and play their own 
significant roles in the response to HG (Donovan & Watts, 2014). An important factor 
that contributes to the roles played by particular sensors in eliciting the endocrine 
response is the rate of onset of HG (Bohland et al., 2014). In slow onset HG (60min), 
peripheral glucose sensors such as the portal mesenteric vein predominate in the 
sympathoadrenal response and involve a central pathway distinct to central glucose 
sensors (Jokiaho et al., 2014). In contrast, during rapid onset HG (20min) central 
glucose sensors mediate the catecholamine release (Bohland et al., 2014). We have 
reached our HG level within 30min of insulin infusion starting, suggesting central 
glucose sensors may be most important in causing the release of Adr in our study. 
 
Potential role for adrenaline in carotid body mediated pathology 
In our experiments we show that Adr stimulates the CB to produce a hyperpnoea during 
acute HG. Chronic recurrent HG, such as iatrogenic HG is an important clinical issue 
and is associated with becoming HG unaware and the development of hypoglycaemia-
associated autonomic failure (HAAF) (Dunn et al., 2007; Arbelaez et al., 2008). HAAF 
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is linked to the attenuation of the sympathoadrenal response to HG rather than a change 
in the action of Adr once released (Moheet et al., 2014). However, chronic CB hyper-
excitation is now emerging as an important driving force in establishing the raised 
arterial blood pressure associated with type II diabetes (Ribeiro et al., 2013) as well as 
chronic heart failure (Schultz et al., 2013), sleep disordered breathing (Narkiewicz et 
al., 1998), and spontaneous hypertension (McBryde et al., 2013). As yet little is known 
of the potential role of Adr in altering CB activity and exacerbating these pathologies. 
Our data suggest that this mechanism warrants further investigation. In a wider context, 
the action of Adr to produce a hyperpnoea during raised metabolic states may also 
implicate a significant role for the CB in matching ventilation to metabolism in other 
physiological situations such as exercise (Parkes, 2013). 
 
Concluding remarks 
In conclusion, this study provides evidence for a role of Adr, a counter-regulatory 
hormone released in response to HG, in provoking the hyperpnoea of hypermetabolism. 
The data generated thus supports a body of literature suggesting that the ventilatory 
response to HG is not mediated by a direct action of low glucose on the CB, but by the 
action of an associated blood-borne mediator, namely Adr. The observation that CO2 
sensitivity is elevated during Adr infusion and HG, and is blocked by the β-antagonist 
Prop and by AdrX, offers a mechanism by which ventilation can be matched to 
metabolism in the absence of a change in PaCO2.  
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Figure Legends 
 
Figure 1: Diagram illustrating the in vivo experimental protocols. A Hyperinsulinaemic 
hypoglycaemia (HG) induced under control conditions and after either adrenalecotomy 
(AdrX) or during propranolol (Prop) infusion. B Adrenaline (Adr) infusion under 
control conditions and after either carotid sinus nerve section (CSNX) or during 
propranolol (Prop) infusion. HC denotes when responses to hypercapnia were tested, * 
denotes when arterial blood samples were taken.  
 
Figure 2: Ventilatory responses to hypoglycaemia (HG) are blocked by adrenalectomy 
(AdrX) and by propranolol (Prop). A Representative trace (5 sec) showing respiratory 
(Airflux, Respiratory Frequency (fR) and Tidal Volume (VT)) and cardiovascular data 
(Arterial Blood Pressure (ABP) and Femoral Blood Flow (FBF)) at baseline and during 
HG. B Minute ventilation ( ሶܸ E) at baseline and in response to HG (n=12) with 
corresponding PaCO2. C Ventilatory response (∆ ሶܸ E) to HG before and after Prop (n=6) 
or AdrX (n=7) with corresponding PaCO2. * denotes p< 0.05, unpaired t-test. 
 
Figure 3: Hypoglycaemia-induced changes in CO2 sensitivity are blocked by both 
propranolol (Prop) and adrenalectomy (AdrX). A HG (n=11) increases CO2 sensitivity 
which is blocked by (B) Prop (n=6) and by (C) AdrX (n=7). * denotes p< 0.05, paired t-
test. 
 
Figure 4: Ventilatory and cardiovascular responses to graded adrenaline (Adr) infusion. 
Minute ventilation ( ሶܸ E) and arterial blood pressure (ABP) were recorded at baseline and 
during infusion of Adr at 0.1, 1 and 10 µg kg min-1. Adr significantly increased ሶܸ E in a 
dose-dependent manner, whilst a significant change in ABP was only seen at the top 
dose (n=30). *, **, *** denotes p<0.05, <0.01, <0.001 respectively one-way ANOVA. 
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Figure 5: Ventilatory responses to adrenaline (Adr) are blocked by propranolol (Prop) 
and by carotid sinus nerve section (CSNX). A Representative trace (5sec) showing 
respiratory (Airflux, Respiratory Frequency (fR) and Tidal Volume (VT)) and 
cardiovascular data (Arterial Blood Pressure (ABP) and Femoral Blood Flow (FBF)) at 
baseline and during Adr infusion. B (i) Minute ventilation ( ሶܸ E) in response to Adr 
infusion with corresponding PaCO2 (n=30). C Ventilatory response (∆ ሶܸ E) to Adr before 
and after Prop (n=14) or CSNX (n=8) with corresponding PaCO2. * denotes p< 0.05, 
unpaired t-test. 
 
Figure 6: Adrenaline (Adr)-induced changes in CO2 sensitivity are blocked by both 
propranolol (Prop) and carotid sinus nerve section (CSNX). A Adr increases CO2 
sensitivity which is blocked by Prop (B) and by CSNX (C). * denotes p< 0.05, paired t-
test. 
 
Figure 7: Carotid body type I cell Ca2+ responses to hypercapnia (HC) are augmented 
by adrenaline (Adr). A Representative trace of paired control responses to HC (15% 
CO2). B Representative trace of paired responses to HC before and during 10 nM Adr 
administration. C Bar chart comparing mean percentage change (±SEM) between 1st 
and 2nd HC challenge for control (n=10) and 10 nM Adr (n=9). * denotes p< 0.05, 
unpaired t-test.  
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